Total planned funding: $261,971,557
Clear active filters
University Research Corporation, LLC
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Uganda | $95,651,603 |
South Africa | $59,496,222 |
Eswatini | $23,300,866 |
Tanzania | $16,879,514 |
Malawi | $16,844,916 |
Lesotho | $9,499,807 |
Central America Region | $7,395,154 |
Botswana | $5,857,626 |
Côte d'Ivoire | $5,317,050 |
Nigeria | $4,592,516 |
Cambodia | $3,762,050 |
Haiti | $3,290,716 |
Kenya | $2,534,935 |
Namibia | $1,591,224 |
Burundi | $1,200,000 |
Zambia | $1,000,000 |
Mozambique | $900,000 |
Indonesia | $860,000 |
Russia | $770,000 |
Rwanda | $650,000 |
Democratic Republic of the Congo | $428,000 |
Western Hemisphere Region | $149,358 |
Organizational Types
Private Contractor | $261,971,557 |
Program Areas
Care | $90,721,332 |
Treatment | $76,561,631 |
Prevention | $51,539,638 |
Governance and Systems | $24,098,401 |
Testing | $13,047,548 |
Management and Operations | $100,000 |
Budget Codes
HTXS: Treatment: Adult Treatment | $67,166,301 |
HVTB: Care: TB/HIV | $46,826,863 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $26,234,795 |
HBHC: Care: Adult Care and Support | $25,124,229 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,227,464 |
HVCT: Testing: HIV Testing and Counseling | $13,047,548 |
HLAB: Laboratory Infrastructure | $12,987,113 |
HKID: Care: Orphans and Vulnerable Children | $12,181,348 |
PDTX: Treatment: Pediatric Treatment | $8,733,799 |
OHSS: Health Systems Strengthening | $8,611,611 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,354,114 |
PDCS: Care: Pediatric Care and Support | $6,588,892 |
HVSI: Strategic Information | $2,499,677 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,094,840 |
HTXD: Treatment: ARV Drugs | $661,531 |
HMIN: Biomedical Prevention: Injection Safety | $628,425 |
HVMS: Management and Operations | $100,000 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |